Citius Pharmaceuticals
CTXR
CTXR
55 hedge funds and large institutions have $16.9M invested in Citius Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more ownership
Funds ownership: 0.39% → 0.39% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
Holders
55
Holding in Top 10
–
Calls
$574K
Puts
$122K
Top Buyers
| 1 | +$263K | |
| 2 | +$152K | |
| 3 | +$95.1K | |
| 4 |
HGWM
Horst & Graben Wealth Management
Portland,
Oregon
|
+$89K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$88K |
Top Sellers
| 1 | -$357K | |
| 2 | -$288K | |
| 3 | -$54K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$48.7K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$40.3K |